Search company, investor...

Cross Pharma

crosspharma.se

Investors Count

2

Funding, Valuation & Revenue

2 Fundings

Cross Pharma's latest funding round was a Acquired Unit - II for on June 25, 2013.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/25/2013

Acquired Unit - II

0

FY undefined

1

4/12/2011

Acquired Unit

0

FY undefined

10

Date

6/25/2013

4/12/2011

Round

Acquired Unit - II

Acquired Unit

Amount

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

Sources

1

10

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Cross Pharma Investors

2 Investors

Cross Pharma has 2 investors. Unimedic invested in Cross Pharma's Acquired Unit - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/25/2013

6/25/2013

1
Acquired Unit - II

Corporation

Sweden

00/00/0000

00/00/0000

Medivir

Subscribe to see more

Corporation

Sweden

First funding

6/25/2013

00/00/0000

Last Funding

6/25/2013

00/00/0000

Investor

Medivir

Rounds

1
Acquired Unit - II

Subscribe to see more

Board Seats

Type

Corporation

Corporation

Location

Sweden

Sweden

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.